Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Paul Bisaro
14 May 2026
Director
Buy
7,500
$3.69
$27.64K
Samraat S. Raha
9 Mar 2026
President and CEO
Buy
40,000
$5.00
$199.84K
S. Louise Phanstiel
27 Feb 2026
Director
Buy
48,000
$4.66
$223.73K
S. Louise Phanstiel
26 Feb 2026
Director
Buy
50,407
$4.80
$242.10K
S. Louise Phanstiel
25 Feb 2026
Director
Buy
6,100
$4.74
$28.89K

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,233,599
History held since 18 Oct 2006